This control plane turns synthetic deviation and CAPA exports into one review surface: root-cause packet continuity, accountable ownership, effectiveness checks, recurrence pressure, retraining evidence, and final batch disposition completeness before downstream handoff.
Biotech teams need one board where root-cause evidence, CAPA ownership, effectiveness checks, recurrence pressure, retraining proof, and final disposition stay readable together.
This fits the Kinetic Gain pattern: routing, evidence, approvals, and operator-safe remediation posture for quality-critical work.
The free surface proves the operator model; the commercial path is an embedded deviation and CAPA module for regulated biotech quality workflows.